About this trial
The purpose of this research study is to evaluate the effectiveness of a hybrid Artificial Intelligence-assisted speech therapy model, which combines the use of an AI speech therapist (Jessica) with traditional speech therapy sessions led by a Speech-Language Pathologist (SLP). This study aims to determine whether the hybrid model improves articulation in children more effectively than traditional SLP-only therapy. Over the course of 8 weeks, participants will receive weekly therapy sessions, and those in the hybrid therapy group will also practice with Jessica between sessions. The study will also gather feedback from parents and speech therapists to assess their experiences and satisfaction with treatment.
Eligibility criteria
Qualifiers
Does the child speak American English as one of their primary languages: Yes
At what age did the child first begin to learn English? Age 4 or younger
Child's current age: > 5 years or < 17 years 8 months
Does the child have any known history of any of the following: autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, epilepsy/antiepileptic medication, or brain injury/neurosurgery/stroke: NO
Disqualifiers
EXCLUSIONARY Response to be filled out by the Parent after sign up.
Does the child speak American English as one of their primary languages: No
At what age did the child first begin to learn English? Age 4 or older
Child's current age: <5 years or > 17 years 8 months
Trial design
Treatments tested in this trial
- Traditional Therapy
- Hybrid therapy
Treatment groups
Sponsors and collaborators
Syracuse University
Lead sponsor
Better Speech
Collaborator